Cargando…

Microvessel density as new prognostic marker after radiotherapy in rectal cancer

BACKGROUND: The extent of angiogenesis is an important prognostic factor for colorectal carcinoma, however, there are few studies concerning changes in angiogenesis with radiotherapy (RTX). Our aim was to investigate changes in tumor angiogenesis influenced by radiotherapy to assess the prognostic v...

Descripción completa

Detalles Bibliográficos
Autores principales: Svagzdys, Saulius, Lesauskaite, Vaiva, Pavalkis, Dainius, Nedzelskienė, Irena, Pranys, Darius, Tamelis, Algimantas
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2666763/
https://www.ncbi.nlm.nih.gov/pubmed/19323831
http://dx.doi.org/10.1186/1471-2407-9-95
_version_ 1782166076352626688
author Svagzdys, Saulius
Lesauskaite, Vaiva
Pavalkis, Dainius
Nedzelskienė, Irena
Pranys, Darius
Tamelis, Algimantas
author_facet Svagzdys, Saulius
Lesauskaite, Vaiva
Pavalkis, Dainius
Nedzelskienė, Irena
Pranys, Darius
Tamelis, Algimantas
author_sort Svagzdys, Saulius
collection PubMed
description BACKGROUND: The extent of angiogenesis is an important prognostic factor for colorectal carcinoma, however, there are few studies concerning changes in angiogenesis with radiotherapy (RTX). Our aim was to investigate changes in tumor angiogenesis influenced by radiotherapy to assess the prognostic value of angiogenesis the microvessel density (MVD) in overall survival after radiotherapy. METHODS: Tumor specimens were taken from 101 patients resected for rectal cancer. The patients were divided into three groups according to the treatment they received before surgery (not treated, a short course, or long course of RTX). Tumor specimens were paraffin-embedded and immunohistochemistry was performed with primary antibody against CD-34 to count MVD. RESULTS: MVD was significantly lower in the group of patients treated with a long course of RTX (p <0.025). The mean MVD for the long RTX group was 134.8; for the short RTX group – 192.5; and for those not treated with RTX – 193.0. There were no significant statistical correlations between MVD and age, sex, grade of tumor differentiation (G) and tumor size (T) in those untreated with RTX. In long RTX group we found a significant prognostic rate for MVD when the density cut off was near 130 with 92.3% sensitivity and 64.7% specificity. When the MVD was lower than a cut off of 130, the survival period significantly increased (p = 0.001), the mortality rate is significantly higher if the MVD is higher than 130 (microvessel/mm(2)) (1953.047; p = 0.002), if the histological grade is moderate/poor (127.407; p = 0.013), if the tumor is T3/T4 (111.618; p = 0.014), and if the patient is male (17.92; p = 0.034) adjusted by other variable in model. CONCLUSION: Our results show that a long course of radiotherapy significantly decreased angiogenesis in rectal cancer tissue. MVD was found to be a favourable marker for tumor behaviour during RTX and a predictor of overall survival after long course of RTX. Further investigations are now needed to determine the changes in angiogenesis during a shorter course of RTX.
format Text
id pubmed-2666763
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26667632009-04-08 Microvessel density as new prognostic marker after radiotherapy in rectal cancer Svagzdys, Saulius Lesauskaite, Vaiva Pavalkis, Dainius Nedzelskienė, Irena Pranys, Darius Tamelis, Algimantas BMC Cancer Research Article BACKGROUND: The extent of angiogenesis is an important prognostic factor for colorectal carcinoma, however, there are few studies concerning changes in angiogenesis with radiotherapy (RTX). Our aim was to investigate changes in tumor angiogenesis influenced by radiotherapy to assess the prognostic value of angiogenesis the microvessel density (MVD) in overall survival after radiotherapy. METHODS: Tumor specimens were taken from 101 patients resected for rectal cancer. The patients were divided into three groups according to the treatment they received before surgery (not treated, a short course, or long course of RTX). Tumor specimens were paraffin-embedded and immunohistochemistry was performed with primary antibody against CD-34 to count MVD. RESULTS: MVD was significantly lower in the group of patients treated with a long course of RTX (p <0.025). The mean MVD for the long RTX group was 134.8; for the short RTX group – 192.5; and for those not treated with RTX – 193.0. There were no significant statistical correlations between MVD and age, sex, grade of tumor differentiation (G) and tumor size (T) in those untreated with RTX. In long RTX group we found a significant prognostic rate for MVD when the density cut off was near 130 with 92.3% sensitivity and 64.7% specificity. When the MVD was lower than a cut off of 130, the survival period significantly increased (p = 0.001), the mortality rate is significantly higher if the MVD is higher than 130 (microvessel/mm(2)) (1953.047; p = 0.002), if the histological grade is moderate/poor (127.407; p = 0.013), if the tumor is T3/T4 (111.618; p = 0.014), and if the patient is male (17.92; p = 0.034) adjusted by other variable in model. CONCLUSION: Our results show that a long course of radiotherapy significantly decreased angiogenesis in rectal cancer tissue. MVD was found to be a favourable marker for tumor behaviour during RTX and a predictor of overall survival after long course of RTX. Further investigations are now needed to determine the changes in angiogenesis during a shorter course of RTX. BioMed Central 2009-03-26 /pmc/articles/PMC2666763/ /pubmed/19323831 http://dx.doi.org/10.1186/1471-2407-9-95 Text en Copyright ©2009 Svagzdys et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Svagzdys, Saulius
Lesauskaite, Vaiva
Pavalkis, Dainius
Nedzelskienė, Irena
Pranys, Darius
Tamelis, Algimantas
Microvessel density as new prognostic marker after radiotherapy in rectal cancer
title Microvessel density as new prognostic marker after radiotherapy in rectal cancer
title_full Microvessel density as new prognostic marker after radiotherapy in rectal cancer
title_fullStr Microvessel density as new prognostic marker after radiotherapy in rectal cancer
title_full_unstemmed Microvessel density as new prognostic marker after radiotherapy in rectal cancer
title_short Microvessel density as new prognostic marker after radiotherapy in rectal cancer
title_sort microvessel density as new prognostic marker after radiotherapy in rectal cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2666763/
https://www.ncbi.nlm.nih.gov/pubmed/19323831
http://dx.doi.org/10.1186/1471-2407-9-95
work_keys_str_mv AT svagzdyssaulius microvesseldensityasnewprognosticmarkerafterradiotherapyinrectalcancer
AT lesauskaitevaiva microvesseldensityasnewprognosticmarkerafterradiotherapyinrectalcancer
AT pavalkisdainius microvesseldensityasnewprognosticmarkerafterradiotherapyinrectalcancer
AT nedzelskieneirena microvesseldensityasnewprognosticmarkerafterradiotherapyinrectalcancer
AT pranysdarius microvesseldensityasnewprognosticmarkerafterradiotherapyinrectalcancer
AT tamelisalgimantas microvesseldensityasnewprognosticmarkerafterradiotherapyinrectalcancer